skip to search skip to navigation skip to main content


For all general enquiries, please call the Astellas Pharma EMEA switchboard on:

Tel:  +44 (0)203 379 8000.

For journalists and media professionals, please call the switchboard on +44 (0)203 379 8000  and request to speak to a member of the Corporate Communications team or contact us by e-mail using the contact form provided, please marking ‘media’ as the nature of your enquiry.

For all other country specific enquiries, please visit our locations page and contact the relevant Astellas office.

Press releases


Astellas Announces Transfer of Qutenza™ to Grünenthal
14th December 2016
Astellas to Acquire Ganymed Pharmaceuticals
28th October 2016
World Anti-Doping Agency and Astellas Announce Global Initiative to Prevent Misuse and Abuse of Medicines for Doping in Sports
14th October 2016
Astellas and LEO Pharma Close Transaction to Transfer Global Dermatology Business
04th April 2016
Astellas Pharma Europe Ltd. Announces New President of EMEA Operations
04th March 2016


How five 15-year olds from Sussex created an antidote to the ‘share everything’ social media culture
21st October 2015
Half of young people are going online to cope with stress, survey shows
21st October 2015
Astellas Pharma EMEA appoints Eugene Van Rensburg as Chief Financial Officer
16th September 2015
Over 550 women’s lives transformed to‐date with Action on Fistula
28th August 2015
European experts reveal new survey data that demonstrates a need for increased focus on ‘the man behind the prostate cancer’
22nd May 2015
Astellas Pharma EMEA celebrates its 10th anniversary
20th May 2015

Terms of Use  |  Privacy Policy  |  Cookies Policy Copyright © 2017 Astellas Pharma Europe Ltd
APEL/16/0024/APEL January 2017